Search results

Selected filters:

News
Life Sciences

Article type

Topic

Sector

Regions

Year

136 results found for your search

Sort options
16 January 2020

Breaking: EPO Board of Appeal upholds invalidation of Broad’s CRISPR-Cas9 patent

Surprise move means Enlarged Board will not now be asked to consider key questions that were referred to it yesterday

04 January 2020

If you thought the last decade was one of big change in IP, you ain't seen nothing yet

Over the last 10 years US patent leadership waned while value creation strategies evolved; but the coming years look set to be dominated by commoditisation, politicisation and, above all else, big data and AI 

19 December 2019

Federal Circuit ruling marks out dangers of doctrine of equivalents estoppel

The CAFC’s Pharma Tech decision provides a series of important pointers on how to avoid amendment-based and argument-based estoppel during prosecution

05 December 2019

The search for the world's leading IP strategists is on

IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value

25 November 2019

Three hidden issues that could affect your China IP transaction

Cross-border deals face regulatory risks that go beyond IP law

18 November 2019

South Africa's top court issues first patent decision but fails to clarify infringement defence uncertainties

The country’s Constitutional Court, which split down the middle, refused to grant an appeal to challenge a Merck patent on new grounds

08 November 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019

08 November 2019

A snapshot of the global patent landscape in eight charts  

A recently issued WIPO report based on multiple data points sheds light on the state of play in worldwide patenting activity

06 November 2019

New report reveals why SMEs want patents and the opportunities they bring

Study released by the European Patent Office sheds light on the growing sophistication of smaller businesses seeking protection for their inventions

02 November 2019

UK general election could result in a paradigm shift on pharma IP

The Labour Party – the main opposition to Boris Johnson’s Conservatives – recently set out a radical plan to change the patent regime for life sciences innovators

31 October 2019

IAM honours Asia’s IP leaders

The winners of our annual Asia IP Elite awards for the teams, deal and individual of the year were revealed before a sold-out crowd at IPBC Asia 2019

26 October 2019

Japan is the unheralded centre of Asia’s patent market

Long-term filing declines and a staid litigation environment mask the fact that the patent strategies pursued by the country’s elite companies are becoming more aggressive and dynamic

11 October 2019

Data reveals strong growth in the number of female inventors, but there is still a long way to go

A report by the UK IP Office finds more women named on patents than ever before – but also that they remain woefully under-represented. We present the top takeaways from a very timely study

08 October 2019

An eyebrow-raising CJEU ruling could be bad news for generics

Europe’s highest court has handed down a surprising decision concerning the consequences of an “unjustified” preliminary injunction issued in a pharma patent case

01 October 2019

The top biopharma patent stories in September

Our round-up of all the major IP developments affecting the life sciences industries last month